2022年7月，一名48岁女性因为持续咳嗽而进行胸部X光检查，发现双侧肺部有多发结节，她接受了胸部计算机断层扫描（CT），结果证实存在多个双侧磨玻璃样混浊，并且肺右下叶基底外侧段存在一个18毫米的实性结节。支气管镜检查显示正常，在支气管冲洗液中检测到 ...

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will ...

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

欧盟委员会的批准基于3期临床试验MARIPOSA的结果。该研究评估了Lazcluze联合Rybrevant，与活性对照osimertinib相比，一线治疗携带上述EGFR变异的NSCLC患者的疗效。分析显示，Rybrevant与Lazcluze联用，与活性对照药物相比，可将疾病进展或死亡风险降低30%。联合疗法与活性对照药物组患者的中位无进展生存期（PFS）分别为23.7个月与16.6个月。此外， ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.

Cancer still eludes treatment, and tumors frequently evolve resistance mechanisms to get around medications. By making cancer ...

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

A DAILY pill that doubles survival time for lung cancer patients will be made routinely available on the NHS. Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery when taken ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...